Proyectos por año
Perfil personal
Research Interests
The overall goal of the research program in Dr. Woodward's lab is to understand the mechanisms of immunological tolerance toward self-antigens.
It is clear that clones of T-lymphocytes with specificity toward self-peptides exist in normal individuals, but that these clones are normally held in check by poorly understood mechanisms, operationally termed peripheral tolerance. Clonal deletion, clonal anergy, and active suppression have all been shown to participate in the generation of peripheral tolerance. A breakdown in peripheral tolerance results in autoimmune disease. One of the key goals of this research is to determine the behavior of the antigen-specific T cell under conditions invoking immunity or tolerance and to understand the signals controlling each process. The Woodward lab is using a model system in which T cells from an ovalbumin-specific, T cell receptor (OVA-TCR) transgenic mouse are adoptively transferred into normal BALB/c mice. Since these OVA-TCR T cells can be visualized with the use of a monoclonal antibody, it is possible to determine the behavior of these T cells following immunization or tolerance induction. Following removal from the mouse, these T cells are analyzed by two and three color immunofluorescent staining and flow cytometry, immunohistochemistry, intracellular cytokine staining, and in vitro culture.
Ongoing projects in the lab concern the role of different tissues in peripheral tolerance induction using the eye as a model system, the role of the antigen-presenting cell in tolerance induction, the ability of tumor cells to escape immune recognition by inducing a state of tolerance and, the production of transgenic mice as models of autoimmune disease to study the role of tolerance in regulating autoimmunity.
Experiencia relacionada con los ODS de las Naciones Unidas
En 2015, los estados miembros de las Naciones Unidas acordaron 17 Objetivos de Desarrollo Sostenible (ODS) para erradicar la pobreza, proteger el planeta y garantizar la prosperidad para todos. El trabajo de esta persona contribuye al logro de los siguientes ODS:
Cuantificación de educación / académica
Post Doctoral Fellow, University Of Southern California
1983
Doctor of Philosophy, University Of Utah
1979
Bachelor of Science, University Of California - Irvine
1975
Huella digital
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
-
Adjuvanted Intranasal Influenza Vaccine to Generate Lung Resident-Memory T Cells
Gandhapudi, S. (PI) & Woodward, J. (CoI)
National Institute of Allergy and Infectious Diseases
8/15/25 → 7/31/27
Proyecto: Research project
-
PILOT: Combination Immunotherapy for PD1 Refractory Tumors
Gandhapudi, S. (PI) & Woodward, J. (CoI)
6/1/25 → 5/31/26
Proyecto: Research project
-
SBIR: Increasing Availability of Emulsion Adjuvants Via Synthetic Biolog
Chappell, J. (PI), Chambers, T. (Former CoI) & Woodward, J. (Former CoI)
10/11/22 → 8/29/26
Proyecto: Research project
-
University of Kentucky Markey Cancer Center - Cancer Center Support Grant (Community Outreach and Engagement (COE))
Evers, B. M. (PI), Adams, V. (CoI), Allison, D. (CoI), Anthony, L. (CoI), Arnold, S. M. (CoI), Bocklage, T. (CoI), Burris, J. (CoI), Butterfield, D. (CoI), Chen, L. (CoI), COHEN, D. (CoI), Durbin, E. B. (CoI), Ellingson, S. (CoI), Gao, T. (CoI), Hands, I. (CoI), Higashi, R. (CoI), Huang, B. (CoI), Hull, P. (CoI), Jeong, J. C. (CoI), Kavuluru, R. (CoI), Kuhs, K. (CoI), Kunos, C. (CoI), Lee, E. (CoI), Liu, J. (CoI), McGarry, R. (CoI), Moseley, H. (CoI), Mullett, T. (CoI), O'Connor, K. (CoI), Patel, R. (CoI), Plattner, R. (CoI), Rogers, J. (CoI), Shelton, B. (CoI), St Clair, D. (CoI), Stanley, S. (CoI), Stapleton, J. (CoI), Sturgill, J. (CoI), Vanderford, N. (CoI), Villano, PhD, J. (CoI), Wang, C. (CoI), Wei, S. (CoI), Weiss, H. (CoI), Williams, L. (CoI), Woodward, J. (CoI), Yan, D. (CoI), Zhang, S. (CoI), Zhou, B. (CoI) & Kolesar, J. (Former CoI)
7/8/13 → 6/30/28
Proyecto: Research project
-
University of Kentucky Markey Cancer Center - Cancer Center Support Grant (Prime)
Evers, B. M. (PI), Adams, V. (CoI), Allison, D. (CoI), Anthony, L. (CoI), Arnold, S. M. (CoI), Bocklage, T. (CoI), Brainson, C. (CoI), Burris, J. (CoI), Burrows Franco, A. (CoI), Chen, L. (CoI), Durbin, E. B. (CoI), Ellingson, S. (CoI), Gandhapudi, S. (CoI), Gao, T. (CoI), Hands, I. (CoI), Hao, Z. (CoI), Higashi, R. (CoI), Huang, B. (CoI), Hull, P. (CoI), Jeong, J. C. (CoI), Kuhs, K. (CoI), Lee, E. (CoI), Liu, J. (CoI), McGarry, R. (CoI), McLouth, L. (CoI), Moseley, H. (CoI), Mullett, T. (CoI), O'Connor, K. (CoI), Patel, R. (CoI), Plattner, R. (CoI), Rogers, J. (CoI), Shelton, B. (CoI), Sturgill, J. (CoI), Vanderford, N. (CoI), Villano, PhD, J. (CoI), Wang, C. (CoI), Wei, S. (CoI), Weiss, H. (CoI), Yan, D. (CoI), Zhang, S. (CoI), Zhou, B. (CoI), Butterfield, D. (Former CoI), COHEN, D. (Former CoI), Kavuluru, R. (Former CoI), Kolesar, J. (Former CoI), Kunos, C. (Former CoI), St Clair, D. (Former CoI), Stanley, S. (Former CoI), Stapleton, J. (Former CoI), Williams, L. (Former CoI) & Woodward, J. (Former CoI)
7/8/13 → 6/30/28
Proyecto: Research project
Producción científica
- 73 Article
-
Unfolded von Willebrand factor binds protein S and reduces anticoagulant activity
Sim, M. M. S., Mollica, M. Y., Alfar, H. R., Hollifield, M., Chung, D. W., Fu, X., Gandhapudi, S., Coenen, D. M., Prakhya, K. S., D Mahmood, D. F., Banerjee, M., Peng, C., Li, X., Thornton, A., Porterfield, J., Sturgill, J. L., Sievert, G. A., Barton-Baxter, M., Zheng, Z. & Campbell, K. y 5 otros, , feb 2025, En: Blood Vessels, Thrombosis and Hemostasis. 2, 1, 100030.Producción científica: Article › revisión exhaustiva
Acceso abierto2 Citas (Scopus) -
R-DOTAP Cationic Lipid Nanoparticles Outperform Squalene-Based Adjuvant Systems in Elicitation of CD4 T Cells after Recombinant Influenza Hemagglutinin Vaccination
Henson, T. R., Richards, K. A., Gandhapudi, S. K., Woodward, J. G. & Sant, A. J., feb 2023, En: Viruses. 15, 2, 538.Producción científica: Article › revisión exhaustiva
Acceso abierto10 Citas (Scopus) -
Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice
Gandhapudi, S. K., Shi, H., Ward, M. R., Bush, J. P., Avdiushko, M., Sundarapandiyan, K., Wood, L. V., Dorrani, M., Fatima, A., Dervan, J., Bedu-Addo, F., Conn, G., Ross, T. M. & Woodward, J. G., feb 2023, En: Viruses. 15, 2, 432.Producción científica: Article › revisión exhaustiva
Acceso abierto10 Citas (Scopus) -
Priming immunotherapy with radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC) and head and neck squamous cell cancer (HNSCC): Interim analysis of phase II clinical trial.
Jacob, A., Kreimer, A., Wei, J., Wu, J., Corum, L., Reusch, E., Woodward, J., Cohen, D., Bondada, S., Adams, V. R., Morgan, R., McGarry, R. C., St Clair, W. H., Kudrimoti, M. R., Myint, Z., Arnold, S. M. & Villano, J. L., may 20 2021, En: Journal of Clinical Oncology.Producción científica: Article
-
Synthetic Biology-derived triterpenes as efficacious immunomodulating adjuvants
Tateno, M., Stone, B. J., Srodulski, S. J., Reedy, S., Gawriluk, T. R., Chambers, T. M., Woodward, J., Chappell, J. & Kempinski, C. F., dic 1 2020, En: Scientific Reports. 10, 1, 17090.Producción científica: Article › revisión exhaustiva
Acceso abierto18 Citas (Scopus)